BlackRock’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-18,300
Closed -$3.79M 5084
2018
Q2
$3.79M Buy
+18,300
New +$3.88M ﹤0.01% 3561
2018
Q1
Sell
-44,000
Closed -$8.36M 5018
2017
Q4
$8.36M Buy
+44,000
New +$8.43M ﹤0.01% 3237

Other funds holding TMO

BlackRock's TMO Position: Q1 2026 in Review

BlackRock reduced its Thermo Fisher Scientific (TMO) stake by 0.82% in Q1 2026, selling an estimated $136M and leaving 30,427,192 shares worth $15B. The position accounts for 0.26% of the portfolio, ranked #60.

BlackRock first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.7B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • BlackRock held 30,427,192 shares of Thermo Fisher Scientific worth $15B as of Q1 2026.
  • BlackRock sold 250,693 Thermo Fisher Scientific shares in Q1 2026, an estimated $136M.
  • Thermo Fisher Scientific made up 0.26% of BlackRock's portfolio in Q1 2026, its #60 holding.
  • BlackRock first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's Thermo Fisher Scientific position peaked at $20.7B in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.